<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>von Ameln Lovison O</submitter><pubmed_abstract>It is argued that commensal bacteria in the upper respiratory tract (URT) protect against pathogen colonization and infection, including respiratory viruses. Given that the microbiome can mediate immune modulation, a link between the URT microbiome (URTM) and COVID-19 susceptibility and severity is expected. This 16S metagenomics cross-sectional study assessed URTM composition, metabolic prediction, and association with laboratory biomarkers in non-COVID-19 pneumonia (NO-CoV), moderate (M-CoV), severe (S-CoV) COVID-19 patients, as well as COVID-19-negative, asymptomatic (NC) patients. The S-CoV group exhibited reduced URTM diversity, primarily due to a decreased abundance of eubiotic taxa. Some of these taxa (e.g., &lt;i>Haemophilus&lt;/i> sp., &lt;i>Neisseria&lt;/i> sp.) were also associated with inf</pubmed_abstract><journal>Frontiers in cellular and infection microbiology</journal><pagination>1531084</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12106449</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Unveiling the role of the upper respiratory tract microbiome in susceptibility and severity to COVID-19.</pubmed_title><pmcid>PMC12106449</pmcid><pubmed_authors>Weber LG</pubmed_authors><pubmed_authors>Barth AL</pubmed_authors><pubmed_authors>Martins AF</pubmed_authors><pubmed_authors>Simon Coitinho A</pubmed_authors><pubmed_authors>von Ameln Lovison O</pubmed_authors><pubmed_authors>Zempulski Volpato FC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unveiling the role of the upper respiratory tract microbiome in susceptibility and severity to COVID-19.</name><description>It is argued that commensal bacteria in the upper respiratory tract (URT) protect against pathogen colonization and infection, including respiratory viruses. Given that the microbiome can mediate immune modulation, a link between the URT microbiome (URTM) and COVID-19 susceptibility and severity is expected. This 16S metagenomics cross-sectional study assessed URTM composition, metabolic prediction, and association with laboratory biomarkers in non-COVID-19 pneumonia (NO-CoV), moderate (M-CoV), severe (S-CoV) COVID-19 patients, as well as COVID-19-negative, asymptomatic (NC) patients. The S-CoV group exhibited reduced URTM diversity, primarily due to a decreased abundance of eubiotic taxa. Some of these taxa (e.g., &lt;i>Haemophilus&lt;/i> sp., &lt;i>Neisseria&lt;/i> sp.) were also associated with inf</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-05-29T17:04:09.725Z</modification><creation>2026-04-08T05:28:09.445Z</creation></dates><accession>S-EPMC12106449</accession><cross_references><pubmed>40433668</pubmed><doi>10.3389/fcimb.2025.1531084</doi></cross_references></HashMap>